Skip to main content
    T

    Tyra Biosciences Inc (TYRA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $19.57
    -0.17 (-0.86%)

    Market Cap: $1.38B

    Last updated: Nov 17, 2026 at 4:33 PM ET

    Tyra Biosciences Inc (TYRA) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Tyra Biosciences (TYRA) has a market cap of $1.38B and an enterprise value of $927.37M. Revenue fell 100.00% over the last 12 months from the 12 months before. Its share count is up 15.77% from a year earlier.

    Total Valuation

    Enterprise value is 32.96% below the market cap, as cash exceeds debt.

    Market Cap$1.38B
    Enterprise Value$927.37M
    Latest price (Nov 17, 2026)$19.57

    Key Dates

    The next earnings report is expected on Mar 1, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 1, 2027 (expected)
    Last Earnings DateNov 10, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 4.68% in the quarter ended Sep 30, 2026 and grew 8.32% a year over 2 years.

    Shares Outstanding69.08M
    Shares Change (YoY)+15.77%
    Shares Change (QoQ)+4.68%
    Share Count Growth (2Y CAGR)+8.32%

    Price Statistics

    The stock is up 24.41% over 52 weeks and trades 8.68% below its 50-day average.

    Beta (1Y)0.59
    52-Week Change+24.41%
    1-Month Change+1.19%
    3-Month Change-27.00%
    6-Month Change-42.07%
    5-Year Change-5.90%
    Total Return (1Y)+24.41%
    Total Return (3Y CAGR)+19.70%
    Total Return (5Y CAGR)-3.86%
    Return vs SPY (1Y)+10.45%
    Max Drawdown (1Y)-53.24%
    Max Drawdown (3Y)-75.32%
    Sharpe Ratio (1Y)0.30
    Correlation with SPY (1Y)0.12
    50-Day Average$21.43
    200-Day Average$29.30
    52-Week Range$15.94 to $40.65
    RSI (14 Days)40.2
    Average Volume (20 Days)628.37K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 23.93x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio23.93x
    Quick Ratio23.93x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -24.51% over the last 12 months, against a 5-year average of -27.10%.

    Return on Equity (ROE)-24.51%
    Return on Assets (ROA)-23.34%
    ROE (5Y Average)-27.10%
    ROA (5Y Average)-25.24%
    ROIC (5Y Average)-40.47%

    Scores

    TYRA has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$132.00K
    Operating Income-$182.40M
    Pretax Income-$169.82M
    Net Income-$169.82M
    Reported EPS (TTM)-$2.64

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 95.23% of the $727.53M in total assets.

    Cash and Equivalents$456.02M
    Total Debt$0
    Net Cash$456.02M
    Net Cash Per Share$6.60
    Working Capital$681.88M
    Shareholder Equity$692.84M
    Book Value Per Share$10.03
    Total Assets$727.53M
    Total Liabilities$34.68M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $301.00K of capital spending, operating cash flow left -$119.78M of free cash flow.

    Operating Cash Flow-$119.48M
    Capital Expenditures$301.00K
    Free Cash Flow-$119.78M
    FCF Per Share-$1.74
    Depreciation and Amortization$538.00K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Book Value Per Share Growth (2Y CAGR)-4.36%
    Tangible Book Per Share Growth (2Y CAGR)-4.36%

    Revenue and profit by year

    Dividends and Yields

    TYRA does not pay a dividend. Its free cash flow yield is -8.86%.

    FCF Yield-8.86%
    Buyback Yield-40.43%
    Shareholder Yield-40.43%

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About TYRA

    What is TYRA's market cap?

    Tyra Biosciences has a market cap of $1.38B. Its enterprise value, which adds debt and subtracts cash, is $927.37M.

    How many shares of TYRA are outstanding?

    Tyra Biosciences has 69.08M shares outstanding. The count is up 15.77% from a year earlier.

    Does TYRA pay a dividend?

    No. Tyra Biosciences does not pay a dividend.

    How much debt does TYRA have?

    Tyra Biosciences has $0 of total debt and $456.02M of cash and equivalents, a net cash position of $456.02M.